These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11896096)

  • 1. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.
    Sloan JA; Goldberg RM; Sargent DJ; Vargas-Chanes D; Nair S; Cha SS; Novotny PJ; Poon MA; O'Connell MJ; Loprinzi CL
    J Clin Oncol; 2002 Mar; 20(6):1491-8. PubMed ID: 11896096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in fluorouracil-induced stomatitis.
    Sloan JA; Loprinzi CL; Novotny PJ; Okuno S; Nair S; Barton DL
    J Clin Oncol; 2000 Jan; 18(2):412-20. PubMed ID: 10637257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
    Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
    Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.
    Chansky K; Benedetti J; Macdonald JS
    Cancer; 2005 Mar; 103(6):1165-71. PubMed ID: 15693031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC GI group experience with high-dose infusional 5-FU in colorectal cancer.
    Blijham GH
    J Infus Chemother; 1996; 6(3):114-7. PubMed ID: 9229320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
    Zaniboni A
    J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
    Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltitrexed-based chemotherapy for advanced colorectal cancer.
    Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy.
    Carlsson G; Odin E; Gustavsson B; Wettergren Y
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):757-63. PubMed ID: 25102934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.
    ; Lévy E; Piedbois P; Buyse M; Pignon JP; Rougier P; Ryan L; Hansen R; Zee B; Weinerman B; Pater J; Leichman C; Macdonald J; Benedetti J; Lokich J; Fryer J; Brufman G; Isacson R; Laplanche A; Quinaux E; Thirion P
    J Clin Oncol; 1998 Nov; 16(11):3537-41. PubMed ID: 9817272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
    Rothenberg ML; Cox JV; DeVore RF; Hainsworth JD; Pazdur R; Rivkin SE; Macdonald JS; Geyer CE; Sandbach J; Wolf DL; Mohrland JS; Elfring GL; Miller LL; Von Hoff DD
    Cancer; 1999 Feb; 85(4):786-95. PubMed ID: 10091755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil.
    Tebbutt NC; Norman AR; Cunningham D; Allen M; Chau I; Oates J; Hill M
    Br J Cancer; 2003 May; 88(10):1510-5. PubMed ID: 12771914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
    J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.